Pharmacotherapy for refractory cancer pain / Ayat Abdelfattah Hassan Mohammad ; Supervised Magdi Ramzi Iskander , Salwa Hefnawy , Gomaa Zohry Hussien
Material type:
- العلاج الدوائى لألام السرطان المستعصيه [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.01.M.Sc.2010.Ay.P (Browse shelf(Opens below)) | Not for loan | 01010110054544000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.01.M.Sc.2010.Ay.P (Browse shelf(Opens below)) | 54544.CD | Not for loan | 01020110054544000 |
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Anaesthesia
The most effective and most appropriate treatment for moderate to severe cancer-induced pain, and they remain the best front-line treatment for cancer pain patients. However, care must be taken to closely monitor patients for potential adverse effects of opioids. Pain is the first symptom of cancer in 20-50% of all cancer patients, and 75-90% of advanced or terminal cancer patients suffer from chronic pain syndrome related to chemotherapy, failed treatment, and/or tumor progression¹ ²
Issued also as CD
There are no comments on this title.